{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:30:12Z","timestamp":1792121412122,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010669","name":"Department of Health of Shandong Province","doi-asserted-by":"publisher","award":["2014WS0178"],"award-info":[{"award-number":["2014WS0178"]}],"id":[{"id":"10.13039\/501100010669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nearly all uterine cervical cancer (UCC) cases result from human papillomavirus (HPV) infection. After high-risk HPV infection, most HPV infections are naturally cleared by humoral and cell-mediated immune responses. Thus, cervical lesions of only few patients progress into cervical cancer via cervical intraepithelial neoplasia (CIN) and lead to persistent oncogenic HPV infection. This suggests that immunoregulation plays an instrumental role in the carcinogenesis. However, there was a few studies on the relation between the immunologic dissonance and clinical characteristics of UCC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We examined the related immune cells (Th1, Th2, Th17, and Treg cells) by flow cytometric analysis and analyzed their relations with UCC stages, tumor size, differentiation, histology type, lymph node metastases, and vasoinvasion. Next, we quantified the Th1, Th2, Th17, and Treg cells before and after the operation both in UCC and CIN patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>When compared with stage I patients, decreased levels of circulating Th1 cells and elevated levels of Th2, Th17, and Treg cells were detected in stage II patients. In addition, the imbalance of Th1\/Th2 and Th17\/Treg cells was related to the tumor size, lymph node metastases, and vasoinvasion. We found that immunological cell levels normalized after the operations. In general, immunological cell levels in CIN patients normalized sooner than in UCC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggested that peripheral immunological cell levels reflect the patient\u2019s condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-020-00972-0","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T08:02:58Z","timestamp":1592380978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The disease stage-associated imbalance of Th1\/Th2 and Th17\/Treg in uterine cervical cancer patients and their recovery with the reduction of tumor burden"],"prefix":"10.1186","volume":"20","author":[{"given":"Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-yuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1144-434X","authenticated-orcid":false,"given":"Fang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"972_CR1","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.2147\/CMAR.S183488","volume":"10","author":"Q Chen","year":"2018","unstructured":"Chen Q, Zeng X, Huang D, Qiu X. Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets. Cancer Manag Res. 2018;10:6489.","journal-title":"Cancer Manag Res"},{"key":"972_CR2","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","volume":"24","author":"DM Parkin","year":"2006","unstructured":"Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine. 2006;24:S11\u201325.","journal-title":"Vaccine"},{"issue":"1","key":"972_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/GCO.0b013e32831a9890","volume":"21","author":"S Patel","year":"2009","unstructured":"Patel S, Chiplunkar S. Host immune responses to cervical cancer. Curr Opin Obstet Gynecol. 2009;21(1):54\u20139.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"10","key":"972_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrc1973","volume":"6","author":"R Roden","year":"2006","unstructured":"Roden R, Wu T-C. How will HPV vaccines affect cervical cancer? Nat Rev Cancer. 2006;6(10):753.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"972_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/aje\/kwn036","volume":"168","author":"J Koshiol","year":"2008","unstructured":"Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(2):123\u201337.","journal-title":"Am J Epidemiol"},{"issue":"13","key":"972_CR6","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/cncr.30667","volume":"123","author":"W Small Jr","year":"2017","unstructured":"Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, et al. Cervical cancer: a global health crisis. Cancer. 2017;123(13):2404\u201312.","journal-title":"Cancer"},{"key":"972_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485\u2013517.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"972_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126(6):1121\u201333.","journal-title":"Cell"},{"issue":"2","key":"972_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cyto.2009.09.007","volume":"49","author":"J Xie","year":"2010","unstructured":"Xie J, Wang J, Tang T, Chen J, Gao X, Yuan J, et al. The Th17\/Treg functional imbalance during atherogenesis in ApoE\u2212\/\u2212 mice. Cytokine. 2010;49(2):185\u201393.","journal-title":"Cytokine"},{"issue":"2","key":"972_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10875-009-9353-1","volume":"30","author":"X Zhu","year":"2010","unstructured":"Zhu X, Ma D, Zhang J, Peng J, Qu X, Ji C, et al. Elevated interleukin-21 correlated to Th17 and Th1 cells in patients with immune thrombocytopenia. J Clin Immunol. 2010;30(2):253\u20139.","journal-title":"J Clin Immunol"},{"issue":"4","key":"972_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","volume":"8","author":"E Bettelli","year":"2007","unstructured":"Bettelli E, Oukka M, Kuchroo VK. T H-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8(4):345.","journal-title":"Nat Immunol"},{"key":"972_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0065-230X(10)07003-X","volume":"107","author":"D Mougiakakos","year":"2010","unstructured":"Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Regulatory T cells in cancer. Adv Cancer Res. 2010;107:57\u2013117 Elsevier.","journal-title":"Adv Cancer Res"},{"key":"972_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00281-006-0022-7","volume":"78","author":"R Wang","year":"2006","unstructured":"Wang R. Regulatory T cells and innate immune regulation in tumor immunity. Springer Semin Immunopathol. 2006;78:17\u201323 Springer.","journal-title":"Springer Semin Immunopathol"},{"issue":"2","key":"972_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/MPA.0000000000000970","volume":"47","author":"M Kieler","year":"2018","unstructured":"Kieler M, Unseld M, Bianconi D, Prager G. Challenges and perspectives for immunotherapy in adenocarcinoma of the pancreas: the cancer immunity cycle. Pancreas. 2018;47(2):142\u201357.","journal-title":"Pancreas"},{"issue":"5","key":"972_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.bbmt.2018.01.019","volume":"24","author":"JP Hwang","year":"2018","unstructured":"Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, et al. Low rate of cervical cancer screening among women with hematologic malignancies after stem cell transplant. Biol Blood Marrow Transplant. 2018;24(5):1094\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"972_CR16","first-page":"3604","volume":"12","author":"W Lin","year":"2019","unstructured":"Lin W, Niu ZY, Zhang HL, Kong Y, Wang Z, Yang XS, Yuan F. Imbalance of Th1\/Th2 and Th17\/Treg during the development of uterine cervical cancer. Int J Clin Exp Pathol. 2019;12(9):3604\u201312.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"972_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"issue":"3","key":"972_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.4049\/jimmunol.1800827","volume":"201","author":"WH Fridman","year":"2018","unstructured":"Fridman WH. From Cancer immune surveillance to Cancer Immunoediting: birth of modern Immuno-oncology. J Immunol. 2018;201(3):825\u20136.","journal-title":"J Immunol"},{"issue":"9","key":"972_CR19","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10(9):942\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"972_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1600-065X.2008.00602.x","volume":"222","author":"I Marigo","year":"2008","unstructured":"Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev. 2008;222(1):162\u201379.","journal-title":"Immunol Rev"},{"issue":"6","key":"972_CR21","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1349-7006.2007.00470.x","volume":"98","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Shima T, Saeki A, Hidaka T, Nakashima A, Takikawa O, et al. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci. 2007;98(6):874\u201381.","journal-title":"Cancer Sci"},{"key":"972_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-0897.2008.00590.x","volume":"60","author":"S Adurthi","year":"2008","unstructured":"Adurthi S, Krishna S, Mukherjee G, Bafna UD, Devi U, Jayshree RS. Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma. Am J Reprod Immunol. 2008;60:55\u201365.","journal-title":"Am J Reprod Immunol"},{"key":"972_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ygyno.2003.09.020","volume":"92","author":"A Fattorossi","year":"2004","unstructured":"Fattorossi A, Battaglia A, Ferrandina G, Buzzonetti A, Legge F, Salutari V, et al. Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients. Gynecol Oncol. 2004;92:106\u201315.","journal-title":"Gynecol Oncol"},{"key":"972_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1349-7006.2009.01153.x","volume":"100","author":"C Loddenkemper","year":"2009","unstructured":"Loddenkemper C, Hoffmann C, Stanke J, Nagorsen D, Baron U, Olek S, et al. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci. 2009;100:1112\u20137.","journal-title":"Cancer Sci"},{"key":"972_CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1746-1596-8-61","volume":"8","author":"ZF Chen","year":"2013","unstructured":"Chen ZF, Ding JB, Pang NN, Du R, Meng W, Zhu YJ, et al. The Th17\/Treg balance and the expression of related cytokines in Uygur cervical Cancer patients. Diagn Pathol. 2013;8:61\u201371.","journal-title":"Diagn Pathol"},{"key":"972_CR26","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cca.2011.01.015","volume":"412","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Ma D, Zhang Y, Tian Y, Wang X, Qiao Y, et al. The imbalance of Th17\/Treg in patients with uterine cervical cancer. Clin Chim Acta. 2011;412:894\u2013900.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"972_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbrc.2008.07.060","volume":"374","author":"B Zhang","year":"2008","unstructured":"Zhang B, Rong G, Wei H, Zhang M, Bi J, Ma L, et al. The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun. 2008;374(3):533\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"972_CR28","doi-asserted-by":"publisher","first-page":"7398","DOI":"10.4049\/jimmunol.177.10.7398","volume":"177","author":"AM Miller","year":"2006","unstructured":"Miller AM, Lundberg K, \u00d6zenci V, Banham AH, Hellstr\u00f6m M, Egevad L, et al. CD4+ CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J Immunol. 2006;177(10):7398\u2013405.","journal-title":"J Immunol"},{"issue":"11","key":"972_CR29","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.4049\/jimmunol.178.11.6730","volume":"178","author":"I Kryczek","year":"2007","unstructured":"Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol. 2007;178(11):6730\u20133.","journal-title":"J Immunol"},{"key":"972_CR30","doi-asserted-by":"publisher","first-page":"24147","DOI":"10.1155\/2007\/24147","volume":"2007","author":"AG Bais","year":"2007","unstructured":"Bais AG, Beckmann I, Ewing PC, Eijkemans MJ, Meijer CJ, Snijders PJ, et al. Cytokine release in HR-HPV. Mediat Inflamm. 2007;2007:24147.","journal-title":"Mediat Inflamm"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-00972-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-020-00972-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-00972-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T21:06:27Z","timestamp":1666991187000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-020-00972-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["972"],"URL":"https:\/\/doi.org\/10.1186\/s12905-020-00972-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.13442\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13442\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13442\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13442\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"3 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was approved by the ethical committee of The Affiliated Hospital of Qingdao University and the written informed consent for participation in the study was obtained from each subject.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}